Hospital
The Health Care Authority for Baptist Health An Affiliate of Uabhs
The Health Care Authority for Baptist Health An Affiliate of Uabhs was paid $5.16M by Medicaid between Jan 2018 and Nov 2024, across 67 billing codes. Its largest line is 99284, emergency room visit (serious) — 25% of everything it billed.
33Billing provider infoTHE HEALTH CARE AUTHORITY FOR BAPTIST HEALTH AN AFFILIATE OF UABHS
PRATTVILLE, AL 36067
PRATTVILLE, AL 36067
33aNPI1942391230assigned 09/28/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$5.16M
24GClaims179,930
24DCodes billed67
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Alabama
Rank by total paid#12 of 77
Median peer was paid$1.13M
This provider vs. median4.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 32,718 | $817K | |
| 2019 | 34,094 | $925K | |
| 2020 | 22,128 | $597K | |
| 2021 | 23,587 | $613K | |
| 2022 | 27,335 | $787K | |
| 2023 | 23,645 | $864K | |
| 2024incomplete | 16,423 | $553K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 25% | 17,651 | 16,886 | $1.27M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 18% | 22,620 | 21,897 | $946K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 13% | 2,450 | 2,319 | $683K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 5.8% | 9,060 | 8,801 | $301K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 5.4% | 2,521 | 2,433 | $277K |
| 80053 | Comprehensive metabolic panel | 5.1% | 21,285 | 20,239 | $265K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.2% | 21,957 | 20,827 | $217K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3.0% | 3,305 | 3,214 | $155K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.2% | 2,024 | 1,956 | $113K |
| 84443 | Thyroid stimulating hormone (TSH) | 2.1% | 5,736 | 5,529 | $110K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 2.1% | 993 | 962 | $107K |
| 80061 | Lipid panel | 1.5% | 4,300 | 4,204 | $77K |
55 more codes
| 82607 | 1.4% | 3,700 | $72K | |
| 87631 | 1.3% | 1,160 | $69K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 4,627 | $49K |
| 84703 | <1% | 7,739 | $48K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 1,011 | $41K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 3,655 | $34K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,504 | $33K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,079 | $32K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 309 | $29K |
| 84484 | <1% | 2,512 | $27K | |
| 81003 | <1% | 13,465 | $22K | |
| 71045 | Radiologic examination, chest; single view | <1% | 3,122 | $18K |
| 83690 | <1% | 2,435 | $17K | |
| 81001 | <1% | 4,024 | $16K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 381 | $16K |
| 84439 | <1% | 1,350 | $16K | |
| 85027 | <1% | 1,818 | $10K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 133 | $10K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 191 | $8K |
| 87070 | <1% | 637 | $8K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 331 | $8K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 382 | $6K |
| 83735 | <1% | 686 | $5K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 412 | $4K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 76 | $4K |
| 85652 | <1% | 768 | $3K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 293 | $3K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 13 | $2K |
| 74022 | <1% | 90 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,642 | $2K |
| 80074 | <1% | 24 | $1K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 120 | $1K |
| 86038 | <1% | 70 | $1K | |
| 87529 | <1% | 13 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 552 | $956.94 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 492 | $940.25 |
| 84481 | <1% | 51 | $912.70 | |
| 87040 | <1% | 57 | $758.25 | |
| 87807 | <1% | 54 | $666.90 | |
| 86430 | <1% | 71 | $571.92 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,827 | $567.22 |
| 86140 | <1% | 239 | $498.42 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 518 | $488.56 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 24 | $486.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 56 | $405.26 |
| 80076 | <1% | 41 | $364.32 | |
| 84702 | <1% | 29 | $325.50 | |
| 76801 | <1% | 14 | $323.52 | |
| 74018 | <1% | 26 | $319.35 | |
| 86780 | <1% | 12 | $307.92 | |
| 73630 | <1% | 14 | $212.24 | |
| 86308 | <1% | 14 | $83.82 | |
| 84100 | <1% | 14 | $61.10 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 134 | $2.90 |
| J7510 | Prednisolone oral, per 5 mg | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBRUTON, CHRISTINE (INTERIM CHIEF FINANCIAL OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Health Care Authority for Baptist Health, An Affiliate of Uabhs | Montgomery, AL | $16.69M |
| Health Care Authority for Baptist Health An Affiliate of Uabhs | Montgomery, AL | $11.99M |
| Health Care Authority for Baptist Health, An Affiliate of Uabhs | Montgomery, AL | $7.48M |
| The Health Care Authority for Baptist Health, An Affiliate of Uabhs | Montgomery, AL | $1.00M |
| The Health Care Authority for Baptist Health | Montgomery, AL | $143K |
| Montgomery Surgical Center, LTD | Montgomery, AL | $79K |
| Health Care Authority for Baptist Health, An Affiliate of Uabhs | Montgomery, AL | $8K |
| Health Care Authority for Baptist Health, An Affiliate of Uabhs | Prattville, AL | $261.54 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.